Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
Health Canada Patents
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 2 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 2 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA I.V.
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 200 mg / 20 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 100 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Brand Name : TREMFYA ONE-PRESS
Patent Number : 2635692
Filing Date : 2006-12-28
Strength per Unit : 100 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-28
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
